https://orcid.org/0000-0002-8849-2737
References
- Morillo-Verdugo R, Lazaro-Lopez A, Alonso-Grandes E, et al. Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV. J Multidiscip Healthc. 2022;15:2991–3003. doi:10.2147/JMDH.S392398
- Cantillana-Suárez MG, Robustillo-Cortés MLA, Gutiérrez-Pizarraya A, Morillo-Verdugo R. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study. Eur J Hosp Pharm. 2021;28(Suppl 2):e157–e163. doi:10.1136/ejhpharm-2020-002330
- Morillo-Verdugo R, Margusino-Framiñán L, Monte-Boquet E, et al. Spanish Society of Hospital Pharmacy position statement on telepharmacy: recommendations for its implementation and development. Farm Hosp. 2020;44(4):174–181. English. doi:10.7399/fh.11515
- Margusino-Framiñán L, Monte-Boquet E. Telepharmacy: usefulness, implantation and research. Farm Hosp. 2022;46(7):1–2.
- Sociedad Española de Farmacia Hospitalaria [Spanish Society of Hospital Pharmacy]. Proyecto Mapex: marco Estratégico de Telefarmacia [página web] [Mapex Project: Telepharmacy Strategic Framework [web page]]. Madrid; 2020. Available from: https://www.sefh.es/mapex/cmo-oportunidad.php. Accessed May 9, 2023.